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Abstract: 
Clinical pathways for end-of-life care management are used widely around the world 
and have been regarded as the gold standard. The aim of this review was to assess 
the effects of end-of-life care pathways (EOLCP), compared with usual care (no 
pathway) or with care guided by a different end-of-life care pathway, across all 
healthcare settings (e.g. hospitals, residential aged care facilities, community). We 
searched the Cochrane Register of Controlled Trials (CENTRAL), the Pain, Palliative 
and Supportive Care Review group specialised register, MEDLINE, EMBASE, review 
articles and reference lists of relevant articles. The search was carried out in 
September 2009. All randomised controlled trials (RCTs), quasi-randomised trials or 
high quality controlled before and after studies comparing use versus non-use of an 
EOLCP in caring for the dying were considered for inclusion. The search identified 
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920 potentially relevant titles, but no studies met criteria for inclusion in the review. 
Without further available evidence, recommendations for the use of end-of-life 
pathways in caring for the dying cannot be made. There are now recent concerns 
regarding the big scale roll-out of EOLCP despite the lack of evidence, nurses 
should report any safety concerns or adverse effects associated with such pathways. 
 
* This paper is based on a Cochrane Review published in The Cochrane Library 
2010, Issue 1 (see www.thecochranelibrary.com for information). Cochrane Reviews 
are regularly updated as new evidence emerges and in response to feedback, and 
The Cochrane Library should be consulted for the most recent version of the review. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
Introduction: 
It is well recognised that populations in developed countries are ageing (1). As 
populations age, the pattern of diseases that people die from also changes (2). With 
advanced ageing, there is an increased risk of death from chronic diseases such as 
cancer and heart failure (3) . For example, cancer was estimated to account for 
about 7 million deaths (12% of all deaths) worldwide in 2000 (3). Therefore, palliative 
care has been identified as one of the worldwide public health priorities due to the 
ageing population (2). Palliative care is concerned with "the quality of life of patients 
and families who face life-threatening illness, by providing pain and symptom relief, 
spiritual and psychosocial support from diagnosis to the end of life and bereavement" 
(4). End-of-life care focuses on the last days and hours of life (5) and the need to 
provide high quality care at this time is essential. The needs of dying people may 
include, but are not limited to, knowing when death is coming, understanding what 
can be expected, being able to maintain a sense of control and having their requests 
given preference, having access to information and excellent care, and having 
access to spiritual and emotional support as required (6). Quality end-of-life care 
may vary from person to person and may be difficult to define and accurately 
measure. However, such care should at least include the following domains: quality 
of life, physical symptoms, emotional and cognitive symptoms, advanced care 
planning, functional status, spirituality, grief and bereavement; satisfaction and 
quality of care, as well as caregiver well being (7). Obstacles to quality end-of-life 
care have also been identified and may include failure to recognise treatment futility, 
lack of communication among decision makers, no agreement on a course of end-of-
life care, and failure to implement a timely end-of-life plan of care (8). In recent 
years, there has been a variety of initiatives developed worldwide to target such 
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issues by developing systemic approaches towards end-of-life care. These initiatives 
include programmes such as the National End of Life Care Programme (9), Gold 
Standards Framework in Care Homes (10) and the Liverpool Care Pathway (LCP) 
(11, 12). 
 
Integrated care pathways are documents which outline the essential steps of 
multidisciplinary care in addressing a specific clinical problem. They can be used to 
introduce clinical guidelines and systematic audits of clinical practice (13). The LCP 
is an example of an integrated care pathway specifically for the dying phase of 
palliation.  
 
Historically, dying patients receiving general hospital care tended to lack adequate 
attention from senior medical staff and nursing staff (14). The quality of symptom 
control and basic nursing care were considered to be inadequate (14). It was thought 
that much could be learned from the way patients were cared for in the hospice 
movement (14). The LCP was a model of best practice developed by the Royal 
Liverpool University Trust and the Marie Curie Centre Liverpool (11, 12), based on 
the care received by those in the hospice setting. Other objectives of the pathway 
were to promote cost-effective health care by appropriate prescribing, and avoiding 
crisis interventions and inappropriate hospital admissions. The document is patient-
centred and focuses on the holistic needs of people who are dying. It incorporates 
the physical, psychological, social, spiritual and religious aspects of care (15). The 
LCP defines 19 goals considered essential in the management of dying patients and 
for the care of their relatives/carers after death (11, 12). These goals were 
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established with the issues identified from surveys, focus groups, expert opinion and 
consensus best practice. 
 
Later, several other groups developed care pathways for the dying based on the 
concept of Ellershaw and colleagues (16-18). Whilst the professional conjecture is 
that end-of-life care pathways promote best possible patient outcomes (15), recent 
speculations have suggested possible adverse effects. These adverse effects 
included premature use of the pathway leading to death due to the premature 
diagnosis of imminent death, the care pathway masking the signs in improvement in 
patients and causing carers' dissatisfaction (19, 20). Therefore, a systematic review 
is warranted to substantiate claims as to whether the end-of-life care pathways are 
beneficial or harmful for dying patients and their carers. 
 
Methods 
The primary objective of this review was to assess whether end-of-life care pathways 
improve outcomes of the dying across all healthcare settings (hospitals, residential 
aged care facilities, community). In particular, we aimed to assess the effects on 
symptom severity and quality of life of people who are dying and/or those related to 
the care such as families, caregivers and health professionals. 
 
Search strategies 
The standard methodology of the Cochrane Collaboration was used. We searched 
the Pain, Palliative and Supportive Care Review Group Specialised Register (Sept 
2009), the Cochrane Central Register of Controlled Trials (Issue 4, 2009), Medline, 
EMBASE, CINAHL and PsycINFO. All databases were searched September 2009). 
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The following search terms were used: ‘palliative care’; ‘end-of-life’; ‘terminally ill’; 
‘hospice$’; ‘end-stage’; ‘dying’; ‘critical pathways’; ‘guidelines’; ‘protocol’; 
professional standard’; ‘care plan$ or map$’; ‘clinical or critical or care path$’. The 
dollar sign was used to retrieve all possible derivations of the root words. Hand 
searching of palliative care journals and relevant conference proceedings were 
performed. There was no restriction by language or date of publication. Reference 
lists of all retrieved articles were searched for additional studies.  
 
Inclusion and exclusion criteria 
Two authors reviewed each paper independently. We considered randomised 
controlled trials, controlled clinical trials controlled before and after studies meeting 
explicit inclusion and quality criteria used by the Cochrane Effective Practice and 
Organisation of Care (EPOC) group. To be eligible for review, controlled before and 
after studies had to include (1) contemporaneous data collection, (2) appropriate 
choice of control site and (3) a minimum of two intervention sites and two control 
sites. We did not plan to include any non-controlled studies (21). Participants in the 
included studies were to be patients and families who received care guided by an 
end-of-life care pathway. Participants included may have had different diseases such 
as cancer or organ failure. However, participants who received interventions must 
have been receiving care guided by an end-of-life care pathway for their last days 
and hours of life. There was to have been no restriction on age of the patient, 
diagnosis or setting (hospital, home, nursing home). There was to have been no age 
limit for participants included in this review. 
 
Results 
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In total, 920 titles and abstracts were retrieved in electronic format and assessed. 
 
Included studies 
No studies fulfilled the study eligibility criteria. 
 
Excluded studies 
Twenty eight papers were retrieved in full text and were excluded because the study 
designs did not meet the criteria for included studies. Twenty papers were audits, 
letters or reviews, and were not experimental studies. Eight experimental studies 
were excluded because they did not meet the minimum criteria to be included in this 
review. Table 1 summarises the characteristics of the excluded studies.  
 
INSERT TABLE 1 
 
Discussion 
No RCTs, quasi-experimental studies or controlled before and after studies meeting 
our eligibility criteria were identified for this review. The results of a number of case 
series and non-eligible controlled before-and-after studies indicate that end-of life 
care pathways may have the potential to improve symptom management (22, 23), 
clinical documentation and assessment (16, 23, 24), knowledge of end-of life care 
amongst internal medicine students (25), prescription of medications for end-of-life 
(22, 26), and bereavement levels of relatives (27). However, the effects of pathways 
are difficult to ascertain from these designs. It is also worth noting that no studies 
reported adverse effects of any EOLCP.  
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In the UK, the registered users of the LCP reached over 1800 health care institutions 
across all settings including hospitals, hospices, care homes and community 
services (28). Further, a publication endorsed by the Australian Government (titled: 
Supporting Australians to live well at the End of Life- National Palliative Care 
Strategy 2010), recommended a national roll out of EOLCP across all sectors 
(primary, acute and aged care) in Australia (29). The use of EOLCP has been 
accepted as the gold standard/national end-of-life care policy, despite the fact that 
there is a lack of sound evidence supporting such practice (30). This may be 
because of the ethical issues around randomising patients to a study arm that does 
not include an intervention, which many clinicians, irrespective of the lack of RCTs, 
believe to be effective. However, it is important for policy makers and clinicians to 
note that, such a large scale roll-out of the EOLCP will make good quality research 
ethically impossible (30).  
 
Designing and conducting trials involving the dying is difficult and challenging due to 
methodological and ethical issues (31, 32). These issues may include difficult patient 
recruitment due to the patient being too ill to participate or unable to give informed 
consent, or the heterogeneous nature of palliative populations (33). However, a 
range of other strategies may be considered to make clinical trials possible. These 
include designing shorter term studies, limiting the number of outcomes, undertaking 
frequent follow-ups, advanced consent and proxy consent where appropriate for 
studies involving this population (34).  
 
Although there have not yet been any formal reports of harm associated with the 
EOLCP, there is no guarantee, unless formal measurement has occurred, that 
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implementing EOLCP does not cause harm (35). Therefore, palliative care 
researchers should attempt to investigate end-of-life interventions with the most 
rigorous research methodology possible. It is encouraging to note that one Italian 
cluster randomised trial is now under way to investigate the effects of the EOLCP on 
patients (36).  
 
Implications for practice and research 
This review was unable to find any evidence of effect or harm with the use of end-of-
life pathways in caring for the dying. Without sufficient evidence for improving patient 
outcomes, organisations should await further high quality evidence before the roll-out 
of the EOLCP. With the recent concerns regarding potential harms associated with 
the use of the EOLCP, it is important that clinical nurses document and report any 
suspected safety concerns or adverse effects associated with the pathways to their 
nursing directors or the safety and quality committee in their organisations. Until 
further formal investigation is conducted, documented harms in an organisation may 
suggest further quality and safety measures or discontinuation of the pathways. 
RCTs or other well designed controlled studies are needed for the evaluation of the 
use of end-of-life care pathways in caring for dying people. In future studies, 
outcome measures should include the outcomes of interest in this review in relation 
to patients, families, caregivers and health professionals. These may include 
patients' symptom control, harms, communication between health care team and 
families, caregivers well being, grief and bereavement, staff and caregivers' 
satisfaction, staff confidence, cost of intervention, cost of care, medication use and 
harms. Further, investigations of the effects of such pathways for specific 
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populations are warranted. These specific populations may include, but are not 
limited to, children and patients with end-stage organ failure or dementia. 
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Table 1. Characteristics of excluded experimental studies 
Excluded studies Reasons of exclusion Other characteristics 
Bailey 2005, USA 
(22) 
Before and after study (without 
control) 
Participants: pre=108, post=95 (patients with cancer and end stage disease) 
Pathway: End of life care plan  
Main outcomes: Increased mean number of documented symptoms, number of care-plans, opioid 
medication availability, do-not-resuscitate orders, and the use of restraints in the post intervention group. 
Notes: Changes in the proportion of deaths that occurred in intensive care units and the use of nasogastric 
tubes were not statistically significant. The end of life care plan was part of a larger intervention with a 
focus of improving processes of care. 
 
Bookbinder 2005, 
USA (16) 
Controlled before and after 
study: Non-contemporaneous 
data collection, non-comparable 
sampling 
Participants: Pre=101, post =156 (patients with cancer and end stage disease) 
Pathway: The Palliative Care for Advanced Disease pathway (PCAD) 
Main outcomes: Patients in the experimental units were more likely to have not for resuscitation orders, 
the comparison units were more like to have morphine infusions and cardiopulmonary resuscitation 
 
Luhrs 2005, USA 
(24) 
Controlled before and after 
study: Non-contemporaneous 
data collection, non-comparable 
sampling and does not have at 
least 2 intervention and 2 
control sites 
Participants: pre=28, post=29 (patients from a medical and an oncology unit) 
Pathway: The Palliative Care for Advanced Disease pathway (PCAD) 
Main outcomes: Patients on the PCAD were more likely to have documentation of care goals and plans of 
comfort care, fewer interventions and more symptoms assessed, more symptoms managed as per 
guidelines. 
 
Okon 2004, USA 
(25) 
Controlled before and after 
study: does not have at least 2 
intervention and 2 control sites 
Participants: 54 internal medicine residents (medical officers) 
Pathway: Integrated end-of-life clinical pathway: the PEACE tool 
Main outcomes: Mean end-of-life care knowledge scores of the internal medicine residents were 46% 
higher in the intervention group compared to the control group. 
 
Taylor 2007, New 
Zealand (37) 
Before and after study (without 
control)/ audit 
Participants: pre=20, post=10 (patients in a residential aged care facility) 
Pathway: Liverpool Care Pathway 
Main outcomes: There was an increase in pre-emptive medication prescription within one residential aged 
care facility 
Notes: The pre-post comparison included only medication prescriptions.  
 
Thompson-Hill 
2009, UK (38) 
Before and after study (without 
control)/ audit 
Participants: 20 patients 
Pathway: Supportive care plan 
Main outcomes: Increased documentation and discussion of place of preferred death.  
 
Veerbeek 2008, 
Netherlands (27) 
Before and after study (without 
control) 
Participants: pre=219, post= 253 (patients with cancer and end stage disease) 
Pathway: Liverpool Care Pathway 
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Main outcomes: Documentation of care was significantly more comprehensive compared with the 
baseline period, and the average total symptom burden was significantly lower in the intervention period. 
Veerbeed 2008,  
Netherlands (23)  
Before and after study (without 
control)  
Participants: pre=131, post =141 (patients with cancer and end stage disease and relatives) 
Main outcomes: The relatives had declined levels of bereavement 
Pathway: Liverpool Care Pathway 
Notes: Only 59% of relatives filled in the questionnaires. Relatives who filled in the questionnaires may be 
those who had higher satisfaction with the use of the pathway and the service.   
 
 
 
 
 
 
 
